Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laszlo Bajzar

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|May 7, 2004
The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instabilityJohn B Walker, Laszlo Bajzar
Critical Care Medicine|May 1, 2004
Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysisLaszlo Bajzar, Nidhi Jain, Ping Wang, et al.
Blood|July 24, 2007
Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenonTanya M Binette, Fletcher B Taylor, Glenn Peer, et al.
Current Opinion in Pediatrics|February 14, 2006
Thrombosis in children with malignancyLaszlo Bajzar, Anthony K Chan, Mary Patricia Massicotte, et al.
The Journal of Biological Chemistry|March 20, 2003
Stabilization versus inhibition of TAFIa by competitive inhibitors in vitroJohn B Walker, Bernadette Hughes, Ian James, et al.
Thrombosis and Haemostasis|January 10, 2009
Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeutic levelsMary E Bauman, Mark J Belletrutti, Laszlo Bajzar, et al.
Thrombosis and Haemostasis|June 4, 2008
Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarinMary E Bauman, Karina L Black, Mary P Massicotte, et al.
British Journal of Haematology|July 22, 2006
Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro studyStefan Kuhle, Alice Lau, Laszlo Bajzar, et al.
The Journal of Laboratory and Clinical Medicine|April 16, 2004
Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activityMark W C Hatton, Suzanne M R Southward, Kimberly J Legault, et al.
The Journal of Biological Chemistry|March 7, 2003
Overexpression of the 78-kDa glucose-regulated protein/immunoglobulin-binding protein (GRP78/BiP) inhibits tissue factor procoagulant activityLindsay M Watson, Anthony K C Chan, Leslie R Berry, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|May 7, 2004
The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instabilityJohn B Walker, Laszlo Bajzar
Critical Care Medicine|May 1, 2004
Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysisLaszlo Bajzar, Nidhi Jain, Ping Wang, et al.
Blood|July 24, 2007
Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenonTanya M Binette, Fletcher B Taylor, Glenn Peer, et al.
Current Opinion in Pediatrics|February 14, 2006
Thrombosis in children with malignancyLaszlo Bajzar, Anthony K Chan, Mary Patricia Massicotte, et al.
The Journal of Biological Chemistry|March 20, 2003
Stabilization versus inhibition of TAFIa by competitive inhibitors in vitroJohn B Walker, Bernadette Hughes, Ian James, et al.
Thrombosis and Haemostasis|January 10, 2009
Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeutic levelsMary E Bauman, Mark J Belletrutti, Laszlo Bajzar, et al.
Thrombosis and Haemostasis|June 4, 2008
Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarinMary E Bauman, Karina L Black, Mary P Massicotte, et al.
British Journal of Haematology|July 22, 2006
Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro studyStefan Kuhle, Alice Lau, Laszlo Bajzar, et al.
The Journal of Laboratory and Clinical Medicine|April 16, 2004
Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activityMark W C Hatton, Suzanne M R Southward, Kimberly J Legault, et al.
The Journal of Biological Chemistry|March 7, 2003
Overexpression of the 78-kDa glucose-regulated protein/immunoglobulin-binding protein (GRP78/BiP) inhibits tissue factor procoagulant activityLindsay M Watson, Anthony K C Chan, Leslie R Berry, et al.
Pageof 1